← Leaderboards
Mari M Kitahata
University Of Washington
$10,091,204
Attributed
$10,091,204
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $846.9K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,091,204 · 7
By mechanism
P30$7,243,785 · 5
U01$2,353,699 · 1
K23$493,720 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- King Kennard Holmes$42,208,763
- Lisa M Frenkel$29,105,317
- Connie L Celum$55,222,861
- Robert W. Coombs$29,428,054
- Heidi M. Crane$25,961,202
Others in their field
Top investigators on “Cohort”
- David R. Weir · University Of Michigan At Ann Arbor$406,814,098
- George R Seage · Abt Associates, Inc.$297,656,361
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$242,146,554
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
CohortCardiovascular DiseasesResourcesPersonsAntiretroviral TherapyInformation SystemsEpidemiologyTreatment OutcomeLinkClinical ResearchTranslational ResearchHiv InfectionsCollectionCollaborationsLiver DiseasesTrainingClinical DataClinical CareInnovationScientistInternationalResearch PersonnelSpecimenUniversities
Grant awards (26)
Core G: Clinical and Comorbidity Research$593,153
P30 · FY2025 · AI · contact PI
Core G: Clinical and Comorbidity Research$534,501
P30 · FY2024 · AI · contact PI
Core G: Clinical and Comorbidity Research$752,647
P30 · FY2023 · AI · contact PI
Core G: Clinical Cohort and Comorbidity Research$846,888
P30 · FY2022 · AI · contact PI
Core G: Clinical Cohort and Comorbidity Research$764,216
P30 · FY2021 · AI · contact PI
Core G: Clinical Cohort and Comorbidity Research$811,224
P30 · FY2020 · AI · contact PI
Core G: Clinical Cohort and Comorbidity Research$814,404
P30 · FY2019 · AI · contact PI
Core G: Clinical Cohort and Comorbidity Research$606,250
P30 · FY2018 · AI · contact PI
Clinical Epidemiology and Health Services Research (CEHSR)$215,523
P30 · FY2017 · AI · contact PI
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)$403,786
U01 · FY2015 · AA · contact PI
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)$164,958
U01 · FY2015 · AA · contact PI
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)$430,405
U01 · FY2014 · AA · contact PI
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)$424,774
U01 · FY2013 · AA · contact PI
Clinical Epidemiology and Health Services Research (CEHSR)$186,249
P30 · FY2013 · AI · contact PI
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)$473,078
U01 · FY2012 · AA · contact PI
Clinical Epidemiology and Health Services Research$250,012
P30 · FY2012 · AI · contact PI
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)$456,698
U01 · FY2011 · AA · contact PI
Clinical Epidemiology and Health Services Research$299,800
P30 · FY2011 · AI · contact PI
Clinical Epidemiology and Health Services Research$158,725
P30 · FY2010 · AI · contact PI
Clinical Epidemiology and Health Services Research$169,716
P30 · FY2009 · AI · contact PI
Clinical Epidemiology and Health Services Research$168,319
P30 · FY2008 · AI · contact PI
Core-Health Services$72,158
P30 · FY2004 · AI
ANTIRETROVIRAL THERAPY AND LONG-TERM CLINICAL OUTCOMES$125,658
K23 · FY2003 · AI
ANTIRETROVIRAL THERAPY AND LONG-TERM CLINICAL OUTCOMES$125,658
K23 · FY2002 · AI
ANTIRETROVIRAL THERAPY AND LONG-TERM CLINICAL OUTCOMES$125,658
K23 · FY2001 · AI
ANTIRETROVIRAL THERAPY AND LONG-TERM CLINICAL OUTCOMES$116,746
K23 · FY2000 · AI